Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin added to superpotent topical corticosteroid for bullous pemphigoid
2011-004361-32Phase 2Terminated
- Sponsor
- Philipps-Universität Marburg
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of simvastatin in Bullous Pemphigoid (BP) (2 arms), sponsored by Philipps-Universität Marburg. Primary endpoint: Feasibility criteria. Started May 2012; status: terminated.
02
Drugs
simvastatin
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on 2011-004361-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004361-32.